D-0073-2023 Class III Terminated
FDA drug recall D-0073-2023 was initiated by Dr. Reddy's Laboratories, Inc. on Nov 21, 2022 and is designated Class III. Reason for recall: Failed dissolution specifications The recall status is terminated (terminated Aug 28, 2024). Affected quantity: 25,176, 30-count; 22,968 20-count.
Recall Details
- Product Type
- Drugs
- Report Date
- Dec 7, 2022
- Initiation Date
- Nov 21, 2022
- Termination Date
- Aug 28, 2024
- Product Quantity
- 25,176, 30-count; 22,968 20-count
Product Description
Allergy Relief D, Fexofenadine HCL 60mg/Antihistamine, Pseudoephedrine HCL 120mg/Nasal Decongestant, Extended-Release Tablets USP, packaged as (a) 20 count carton NDC 49032-273-20; (b) 30 count carton, NDC49032-273-30; Distributed by: Walmart Inc., Bentonville, AR 72716, Product of India
Reason for Recall
Failed dissolution specifications
Distribution Pattern
Nationwide in the USA
Code Information
Lot# (a) AC2203133B, EXP 01/2024; (b) AC2203133A, EXP 01/2024.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0073-2023
- openFDA file date
- Oct 23, 2026
- Loaded by RegDataLab
- Oct 24, 2026